OBP-401

N/A

Report date: 2023/09/25 11:14:22

Base Information

Drug NameOBP-401
Drug Alias Namehuman telomerase reverse transcriptase (hTERT) gene promoter sequence and a green fluorescent protein (GFP) geneTelomeScanOBP-401
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionTelomerase reverse transcriptase inhibitors
TargetsTelomerase reverse transcriptase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOncolys Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncolys Biopharma Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A